“…Currently, several substances are known to increase the MEPPs amplitude when exogenously applied to mammalian motor synapses: γ‐S‐ATP (Bogacheva & Balezina, 2015), TGF‐β2 (Fong et al., 2010), agonists of endocannabinoid receptors (Morsch et al., 2018), BDNF (Gaydukov, Akutin, Bogacheva, & Balezina, 2018), calcitonin gene‐related peptide (CGRP) (Gaydukov, Bogacheva, & Balezina, 2016). Of these, CGRP is of special interest because this 37‐amino acid neuropeptide has been found in large dense‐core vesicles (LDCVs) in mammalian motor nerve terminals (Csillik et al., 1993; Matteoli et al., 1988) and is reported to be released as a co‐transmitter in response to sustained depolarization or intense nerve stimulation (Sakaguchi, Inaishi, Kashihara, & Kuno, 1991; Sala, Andreose, Fumagalli, & Lømo, 1995; Uchida et al., 1990) providing the wide spectrum of acute and neurotrophic influences (Buffelli, Pasino, & Cangiano, 2001; Changeux, Duclert, & Sekine, 1992; Correia‐de‐Sá & Ribeiro, 1994; Fernandez, Ross, & Nadelhaft, 1999; Kimura, Okazaki, & Nojima, 1997; Machado et al., 2016; Rossi, Dickerson, & Rotundo, 2003; Salim, Dezaki, Tsuneki, Abdel‐Zaher, & Kimura, 1998).…”